Special Promotion: Oncomine cfDNA Assays for Liquid Biopsy Research
Save 25%* off list price when you purchase any trial packs of the new Oncomine™ cell-free DNA (cfDNA) assays and associated barcode sets. Use promotion code RCFDNA when placing your order.
Oncomine cfDNA assays offer several advantages over analysis of solid tumor samples, enabling tumor heterogeneity research, therapy selection research, therapy monitoring research, and reoccurrence research studies from as little as 1 ng of input DNA.
Featured case study: Verifying the potential of cfDNA for lung cancer management in the future
“Using the Oncomine Lung cfDNA Assay, we were able to amplify more difficult samples. The assay allowed us the detection of mutations like EGFR T790M down to 0.14% allelic fraction.”
José Luis Costa, PhD, Senior Researcher, Institute of Molecular Pathology and Immunology of the University of Porto, Portugal
Optimized for liquid biopsy clinical research focused on primary driver and resistance mutations in cfDNA
Oncomine cfDNA assays include targets identified by the Oncomine™ Knowledgebase, a cancer genomics data resource, and reviewed by clinical researchers.